July 9, 2003
The Board of Directors and Stockholders of Rigel Pharmaceuticals, Inc.
We are aware of the incorporation by reference in the Registration Statement (Form S-3) of Rigel Pharmaceuticals, Inc. for the registration of 9,583,331 shares of its common stock, and in the related prospectus contained in such Registration Statement, of our report dated April 21, 2003, relating to the unaudited condensed interim financial statements of Rigel Pharmaceuticals, Inc. that are included in its Form 10-Q for the quarter ended March 31, 2003.
As noted above, under Rule 436(c) of the Securities Act of 1933, our report is not a part of the registration statement prepared or certified by accountants within the meaning of section 7 or 11 of the Securities Act of 1933.
| Very truly yours, | ||
| /s/ ERNST & YOUNG LLP |